Search Results < Pharmacology

276 results

News
Researchers Decode Targets for Hundreds of Signaling Enzymes
Kinases are essential for cell signaling. A new study matches kinases to their targets, enabling a deeper understanding of biological processes.
Source: YaleNews
15 Feb 2023
News
Researchers decode targets for hundreds of signaling enzymes
Kinases are essential for cell signaling. A new study matches hundreds of kinases to their targets, enabling a deeper understanding of biological processes.
Source: Yale News
14 Feb 2023
News
Eight Yale Faculty Take Home Awards at the 2022 Yale Life Sciences Pitchfest
The 2022 Yale Life Science Pitchfest held on December 8, 2022 featured 31 Yale faculty innovators presenting breakthrough research projects in therapeutics, medical devices, and digital health to a crowd of over 325 people from 120+ companies, including 14 industry judges.
Source: Yale Ventures
13 Dec 2022
News
Eight Yale Faculty Take Home Awards at the 2022 Yale Life Sciences Pitchfest
The 2022 Yale Life Science Pitchfest held on December 8, 2022 featured 31 Yale faculty innovators presenting breakthrough research projects in therapeutics, medical devices, and digital health to a crowd of over 325 people from 120+ companies, including 14 industry judges.
Source: Yale Ventures
12 Dec 2022
News
Why Some Lung Tumors Respond Better to Targeted Therapies Than Others
In a new study, Yale Cancer Center researchers found molecular explanations for why some lung tumors respond better to certain drugs than others. The research should help improve drug selection for lung cancer patients with different mutations in the EGF receptor, using a precision medicine approach to treatment.
5 Dec 2022
News
Lemmon Will Be the Next Chair of Pharmacology
Mark A. Lemmon, PhD, will become chair of the Department of Pharmacology in July 2023.
22 Nov 2022
News
Lung Cancer Awareness Q&A with Roy Herbst, MD, PhD
Q&A with Roy Herbst, MD, PhD, medical oncologist, in recognition of Lung Cancer Awareness Month.
15 Nov 2022
News
Yale Researchers Awarded $12M NIH Grant to Study Impact of FGF21 Protein on Aging
Researchers from Yale University, and the University of Texas Southwestern Medical Center have been awarded a $12.4 million, five-year grant from the National Institute on Aging of the NIH to deploy their unique research models and expertise in a coordinated fashion to develop a novel course of gerontological research.
24 Oct 2022
News
Yale Cancer Center Members Receive Faculty Innovation Awards
The annual Yale Faculty Innovation Awards are an opportunity to recognize the significant contributions of faculty investigators who launch startups in order to address global challenges.
12 Oct 2022
News
Y-TRIC T32 Post-doctoral Research Fellowship Offers Multi-modality Cardiovascular Imaging Training
The Yale Translational Research Imaging Center (Y-TRIC) is recruiting T32 post-doctoral fellows.
12 Oct 2022
News
The Roots of Biodiversity: How Proteins Differ Across Species
The traits of a particular species are not merely the result of its genes but also the proteins for which those genes code. Understanding the differences among species’ proteomes—or all of the proteins that can be expressed—is, therefore, as important as understanding differences among genomes.
Source: YaleNews
19 Sep 2022
News
Study from Yale Cancer Biologists Identifies Chromatin Regulator WDR5 as Possible Drug Target in Triple-Negative Breast Cancer
A new study from Yale Cancer Center scientists has identified the chromatin regulator WDR5 as a possible new drug target in triple negative breast cancer.
31 Aug 2022
News
To break through bacteria’s protective shield, target the shield-maker
Dr. Wei Mi's group reveals the mechanism for how E. coli cells decide to synthesize the right amount of lipopolysaccharide
Source: YaleNews
10 Aug 2022
News
To Break Through Bacteria’s Protective Shield, Target the Shield-maker
Yale researchers have now uncovered a key part of the process that generates an additional protective layer of the cell wall of bacteria, a finding that may help reveal vulnerabilities that could be targeted by new antibiotics.
Source: YaleNews
10 Aug 2022
News
Yale Cancer Center Diversity Enhancement Program in Oncology welcomes first students
The Diversity Enhancement Program in Oncology program offers an eight-week rotation for two underrepresented in medicine (URiM) students or residents, and is designed to provide exposure to hematology/medical oncology as a career, provide faculty-mentored clinical experience in oncology as well as with a corresponding clinical or translational research project. Students also receive co-mentorship from current Medical Oncology-Hematology T32 fellows.
3 Aug 2022
News
New Drug Combination Lengthens Survival for Some With Lung Cancer
A combination of the drugs ramucirumab and pembrolizumab reduced risk of death by 31% compared with the standard of care in patients with advanced non-small cell lung cancer that had progressed on prior immunotherapy.
3 Jun 2022
News
Single Cell Analysis Technologies Help Generate Unprecedented Maps of Disease
Yale researchers across disciplines are using single cell technologies to profile various kinds of cells that exist together in both healthy and diseased organs and create the most detailed blueprints of diseases to date, as well as to better understand how various cells develop over time and interact with one another.
20 May 2022
News
Yale Scientist Receives Connecticut Medal of Technology for Pioneering Work
Crews was awarded the medal for his pioneering research that launched the pharmaceutical field of targeted protein degradation.
Source: YaleNews
16 May 2022
News
PROTAC Research Takes Aim at Drug Resistant Prostate Cancer
A new class of cancer drugs is being investigated to target drug resistant prostate, lung, and colorectal cancers. Findings from Yale scientists...
16 May 2022
News
Dr. Roy S. Herbst honored at Friends of Cancer Research 25th Anniversary Dinner
The evening of May 10, 2022, the Friends of Cancer Research held their 25th Anniversary Dinner Celebration at the Four Seasons Hotel in Washington, DC. Roy S. Herbst, MD, PhD, was recognized at the event for his contributions in lung cancer as one of the foremost leaders in lung cancer treatment and research.
11 May 2022